Vitamins and blood homocysteine levels

One of December's biggest stories involved an intriguing study on the potential benefits of using vitamins to lower blood homocysteine levels, and therefore heart disease risk, among middle-aged people. Lead authors Gilbert S. Omenn, M.D., Ph.D. and Brahmajee Nallamothu, M.D., and their colleagues used risk and cost information to show that it's worth it for people to make sure they get the recommended doses of folic acid and vitamin B12 to bring their homocysteine levels down, even though the exact health impact of low homocysteine is not yet known. The story received widespread national and international attention. A press release is available here.

December also brought the first round of grants awarded to the U-M's medical researchers as part of the state's Life Sciences Corridor initiative funded by tobacco lawsuit settlement money for initiatives at institutions and companies across Michigan. Overall, U-M-led teams received $47.8 million in grants and made up almost half of the teams receiving funding. Among other projects, the U-M will house two core facilities: the $12 million Michigan Proteome Consortium, and the $9 million Michigan Center for Biological Information.

About The Author:

Doug Murphy is a successful author and regular contributor to http://www.1st-in-vitamins.com. Recommending the best vitamins, minerals, herbs and weight loss products for optimum health.